Synthesizing method of eplerenone

A technology of eplerenone and a synthesis method, which is applied in the field of synthesis of steroidal antihypertensive drug eplerenone, can solve the problems of high price and the like

Inactive Publication Date: 2016-07-13
BEIJING VENTUREPHARM BIOTECH
View PDF11 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, many domestic patents have also done relevant reports (CN101121652, CN1724557, CN1749266), but the key part of the synthesis is all concentrated in the construction of the methyl carboxylate structural unit of the C-7 α configuration, which requires the use of highly toxic cyanide Compound reagents, while cyano conversion requires expensive DIBAH reagents; or under harsh conditions such as ozone and low temperature (-78°C)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesizing method of eplerenone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Implementation Example 1: Synthesis of 7α-(5-methyl-2-furan)-11α-hydroxycanrenone (Ⅱ)

[0019] Add 26.5 g of 11α-hydroxycanrenone to a 500 mL three-neck flask under nitrogen protection, dry 210 mL of nitromethane and 50 mL of dichloromethane. Cool to -22°C, add 12.5g of 2-methylfuran, 45g of anhydrous methanol, and 12g of boron trifluoride etherate in sequence, and keep stirring at -16 to 20°C for 30 hours. Add 52 mL of 15% ammonia water to terminate the reaction. The reaction solution was extracted with dichloromethane, dried over anhydrous sodium sulfate for 4 hours, filtered with suction, and the filtrate was concentrated. The obtained solid was recrystallized with a mixed solvent of ethyl acetate and dichloromethane at a volume ratio of 4:1, filtered, and the filter cake was stored at 40°C Dry in a blast drying oven for 12 hours to obtain a white solid powder with a yield of 75.6%.

Embodiment 2

[0020] Example 2: Synthesis of 7α-(5-methyl-2-furan)-11α-p-methylsulfonylcanrenone (Ⅲ):

[0021] Add 25.0 g of compound II and 125 mL of chloroform into a 500 mL three-necked flask. Cool to 0°C, add 70 mL of anhydrous pyridine, dissolve and add 32.5 g of p-toluenesulfonyl chloride. After 4 hours of reaction, the temperature was naturally raised to 25° C., and the stirring reaction was continued for 22 hours. Add 80 g of water to terminate the reaction, collect the organic phase by liquid separation extraction, dry over anhydrous sodium sulfate for 4 hours, filter, concentrate the filtrate, and recrystallize the solid with a mixed solvent of acetone and ethanol at a volume ratio of 1:2. After filtering, the filter cake was dried in a blast oven at 40°C for 12 hours to obtain a white solid powder with a yield of 90.7%.

Embodiment 3

[0022] Implementation example three: the synthesis of compound IV:

[0023] Add 30.0 g of compound III and 47.0 g of anhydrous sodium acetate into a 500 mL three-necked flask, add 180 mL of anhydrous formic acid, heat to 80° C. for 3 hours, and the reaction is complete. The formic acid was distilled off under reduced pressure, and the residue was added with dichloromethane and water, and separated and extracted. The organic layer was washed with saturated sodium bicarbonate solution, separated, the organic layer was dried with anhydrous sodium sulfate for 4 hours, filtered, the filtrate was concentrated, and the solid was recrystallized with a mixed solvent of ethanol and acetone at a volume ratio of 3:1 to obtain a white filter cake, which was collected rate of 64.5%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a novel synthesizing method of a steroid drug eplerenone.According to the synthesizing method, 11-alpha-hydroxycarvenone serves as the starting material, and eplerenone is generated through a series of reactions such as addition, substitution, elimination, oxidation, esterification and epoxidation.According to the synthesizing method of eplerenone, the starting material is low in price and easy to purchase, operation is simple and easy to control, the yield is high, the cost is low, and the method is suitable for industrial production.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a synthesis method of a steroidal antihypertensive drug eplerenone in the field of medicinal chemistry. Background technique [0002] Eplerenone was prepared by Ciba-GeigyAg in Switzerland in 1984 and was approved by the US FDA in 2002. Its structural formula is as follows: [0003] . [0004] Eplerenone is mainly used to treat essential hypertension and heart failure after myocardial infarction, and it is also the first selective aldosterone receptor blocker approved for marketing. It has good selectivity for aldosterone receptor, long half-life and good tolerance. Eplerenone may be used to improve survival in patients with congestive heart failure after an acute heart attack. The synthesis work of eplerenone has related patents and literature reports at home and abroad, and the early synthesis work was mainly completed by the GrobJ. group of Ciba-GeigyAg Company in Swit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07J71/00
CPCC07J71/0015
Inventor 范丽丽赵国磊
Owner BEIJING VENTUREPHARM BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products